Literature DB >> 1476004

Expression of influenza neuraminidase in baculovirus-infected cells.

K A Mather1, J F White, P J Hudson, J L McKimm-Breschkin.   

Abstract

Recombinant influenza neuraminidase (NA, subtype 2, A/NT/60/68) was produced by recombinant baculovirus-infected insect cells. The recombinant NA retained enzyme activity and was located on the cell surface. Enzyme activity was both cell-associated and in the cell free supernatant; maximal NA activity was found in the supernatant. Recombinant NA was recognised by polyclonal antisera and by three monoclonal antibodies specific for NA (subtype 2). Enzyme activity was also neutralised by polyclonal antisera. Recombinant NA thus retains most of the immunological and activity properties of authentic influenza NA. Immunoprecipitation of [35S]Methionine-labelled cells and supernatant and partial purification of NA indicated that a approximately 50-kDa form of NA was present in the supernatant, whilst the expected size (approximately 67-kDa) was cell-associated. Purified recombinant extracellular virus was also enzymatically active, and contained the 67-kDa NA which was located on the membrane capsule of the virus. This suggests that the virus had acquired the cell-associated form of recombinant NA during the budding process from the cell.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1476004     DOI: 10.1016/0168-1702(92)90152-y

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  10 in total

1.  Reduced susceptibility to all neuraminidase inhibitors of influenza H1N1 viruses with haemagglutinin mutations and mutations in non-conserved residues of the neuraminidase.

Authors:  Jennifer L McKimm-Breschkin; Janelle Williams; Susan Barrett; Kim Jachno; Mandy McDonald; Peter G Mohr; Takehiko Saito; Masato Tashiro
Journal:  J Antimicrob Chemother       Date:  2013-06-11       Impact factor: 5.790

2.  Structure of an Influenza A virus N9 neuraminidase with a tetrabrachion-domain stalk.

Authors:  Victor A Streltsov; Peter M Schmidt; Jennifer L McKimm-Breschkin
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2019-01-23       Impact factor: 1.056

3.  Evaluation of antibody response in mice against avian influenza A (H5N1) strain neuraminidase expressed in yeast Pichia pastoris.

Authors:  Murugan Subathra; Ponsekaran Santhakumar; Mangamoori Lakshmi Narasu; Syed Sultan Beevi; Sunil K Lal
Journal:  J Biosci       Date:  2014-06       Impact factor: 1.826

4.  Identification of Residues That Affect Oligomerization and/or Enzymatic Activity of Influenza Virus H5N1 Neuraminidase Proteins.

Authors:  Meiling Dai; Hongbo Guo; Jos C F M Dortmans; Jojanneke Dekkers; Johan Nordholm; Robert Daniels; Frank J M van Kuppeveld; Erik de Vries; Cornelis A M de Haan
Journal:  J Virol       Date:  2016-09-29       Impact factor: 5.103

5.  Design of the Recombinant Influenza Neuraminidase Antigen Is Crucial for Its Biochemical Properties and Protective Efficacy.

Authors:  Jin Gao; Laura Klenow; Lisa Parsons; Tahir Malik; Je-Nie Phue; Zhizeng Gao; Stephen G Withers; John Cipollo; Robert Daniels; Hongquan Wan
Journal:  J Virol       Date:  2021-10-06       Impact factor: 5.103

Review 6.  Cell-based influenza vaccines: progress to date.

Authors:  Jennifer M Audsley; Gregory A Tannock
Journal:  Drugs       Date:  2008       Impact factor: 9.546

7.  A generic system for the expression and purification of soluble and stable influenza neuraminidase.

Authors:  Peter M Schmidt; Rebecca M Attwood; Peter G Mohr; Susan A Barrett; Jennifer L McKimm-Breschkin
Journal:  PLoS One       Date:  2011-02-07       Impact factor: 3.240

8.  Detection of NP, N3 and N7 antibodies to avian influenza virus by indirect ELISA using yeast-expressed antigens.

Authors:  Chitra Upadhyay; Arun Ammayappan; Vikram N Vakharia
Journal:  Virol J       Date:  2009-10-07       Impact factor: 4.099

9.  Expression and Characterization of Recombinant, Tetrameric and Enzymatically Active Influenza Neuraminidase for the Setup of an Enzyme-Linked Lectin-Based Assay.

Authors:  Marua Prevato; Ilaria Ferlenghi; Alessandra Bonci; Yasushi Uematsu; Giulia Anselmi; Fabiola Giusti; Sylvie Bertholet; Francois Legay; John Laird Telford; Ethan C Settembre; Domenico Maione; Roberta Cozzi
Journal:  PLoS One       Date:  2015-08-17       Impact factor: 3.240

10.  Aurintricarboxylic acid inhibits influenza virus neuraminidase.

Authors:  Hui-Chen Hung; Ching-Ping Tseng; Jinn-Moon Yang; Yi-Wei Ju; Sung-Nain Tseng; Yen-Fu Chen; Yu-Sheng Chao; Hsing-Pang Hsieh; Shin-Ru Shih; John T-A Hsu
Journal:  Antiviral Res       Date:  2008-11-17       Impact factor: 5.970

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.